Dominari Holdings Inc. (FRA:BP2A)

Germany · Delayed Price · Currency is EUR

3.520

-0.040 (-1.12%)

At close: Dec 5, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2019	FY 2018	FY 2017	2000 - 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2000 - 2016
Dominari Financial	18.15M	Log In	Log In	Log In	Log In	Upgrade
Dominari Financial Growth	789.95%	Log In	Log In	Log In	Log In	Upgrade
Small-molecule Anticancer and Antiviral Therapeutics	-	Log In	Log In	Log In	Log In	Upgrade
Small-molecule Anticancer and Antiviral Therapeutics Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2019	FY 2018	FY 2017	2000 - 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2000 - 2016
United States	18.15M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	789.95%	Log In	Log In	Log In	Log In	Upgrade